insights_auto
Why is RGEN up 4.29%?
Dive Deeperchevron_right
RGEN:NASDAQ
Repligen Corp
$189.50
arrow_upward
+4.29%(+7.80) 1D
$189.50
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 5, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RGEN...
Open
$178.75
High
$191.26
Low
$178.61
Mkt. cap
10.69B
Avg. vol.
1.08M
Volume
0.00
P/E ratio
258.30
52-wk high
$198.86
52-wk low
$100.99
EPS
$0.73
Beta
1.08
Shares outstanding
56.44M
No. of employees
2K
Open
$178.75
High
$191.26
Low
$178.61
Mkt. cap
10.69B
Avg. vol.
1.08M
Volume
0.00
P/E ratio
258.30
52-wk high
$198.86
52-wk low
$100.99
EPS
$0.73
Beta
1.08
Shares outstanding
56.44M
No. of employees
2K
News stories
From web sources and news partners
GuruFocus
·
9 hours ago
Repligen Corp (RGEN) Stock Up 4.3% but GF Value Says Overvalued -- GF Score: 85/100
Stock Titan
·
12 hours ago
Loeillot proposes selling 4,202 Repligen (RGEN) shares through Fidelity.
Investing.com Canada
·
14 hours ago
Form 144 REPLIGEN CORP For: 5 October By Investing.com
Stocktwits
·
1 week ago
Why Did KOD, RGEN, BIIB Stocks Rise To 52-Week Highs?
Profile
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN. Wikipedia
About Repligen Corp
CEOTony J. Hunt
Employees2K
Founded1981
HeadquartersWaltham, Massachusetts, United States
SectorHealth care
Websiterepligen.com